672 filings
Page 4 of 34
8-K
vhub7nlm
10 May 22
Results of Operations and Financial Condition
8:30am
8-K
uvj1ln81xd6ft5q5
29 Apr 22
Departure of Directors or Certain Officers
4:37pm
S-8
5z950pzrid 0r40s494
27 Apr 22
Registration of securities for employees
4:48pm
DEFA14A
ej46l7gwe 4ill91b
14 Apr 22
Additional proxy soliciting materials
4:19pm
8-K
j7k32apap gm89u1
23 Mar 22
ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors
4:15pm
8-K
e6eqbb1c vrfa
15 Mar 22
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth
8:30am
8-K
batypc4z hii
28 Feb 22
Departure of Directors or Certain Officers
4:34pm
8-K
dsjspjpa1esgrfpu
15 Feb 22
Other Events
4:10pm
8-K
gtoehvh1ee32c3
24 Jan 22
Other Events
4:17pm
424B3
yv10 wviozzi3nbj
19 Jan 22
Prospectus supplement
4:14pm
EFFECT
xhgdjzku
19 Jan 22
Notice of effectiveness
12:15am
CORRESP
5dqhh4jsij434
13 Jan 22
Correspondence with SEC
12:00am
UPLOAD
i6nhs0yd foxm1nu0va2
28 Dec 21
Letter from SEC
12:00am
8-K
gpmhc751p4z ew9k
26 Nov 21
ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly
12:00am
424B5
agim bcidjdkj3wu5m
5 Nov 21
Prospectus supplement for primary offering
12:00am
8-K
9uegwn
4 Nov 21
Entry into a Material Definitive Agreement
5:20pm
424B5
ohtp09
3 Nov 21
Prospectus supplement for primary offering
4:14pm